21 – 30 of 2082
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Immunosuppressants for IgG4-related disease
- Contribution to journal › Article
-
Mark
Endogenous vasopressin and vasopressin receptor 2 in bladder as anti-diuretic / anti-spasmodic targets for the treatment of multifactorial nocturia
- Contribution to journal › Article
-
Mark
ProToxin, a Predictor of Protein Toxicity
- Contribution to journal › Article
-
Mark
Authors’ reply to Chaker Ben Salem’s comment on : “Drug-Induced Cognitive Impairment”
- Contribution to journal › Letter
- 2024
-
Mark
Dose-dependent effects of acetaminophen and ibuprofen on mitochondrial respiration of human platelets
- Contribution to journal › Article
-
Mark
Presynaptic nanoscale components of retrograde synaptic signaling
- Contribution to journal › Article
-
Mark
Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking
- Contribution to journal › Article
-
Mark
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders
- Contribution to journal › Scientific review
-
Mark
Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH
- Contribution to journal › Article
-
Mark
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ
- Contribution to journal › Article
